Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

CAR T-Cell Therapy Targeting GPRC5D Antigen Proves Effective in First Trial in Patients with Resistant Multiple Myeloma

Eric Smith, MD, PhD
September 28, 2022
A therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein produced impressive results in its first clinical trial in patients with multiple myeloma, researchers at Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center and Roswell Park Comprehensive...
Read Story
  • Explore the Newsroom and Our Publications

    News Releases

    See our news releases about cancer care, cancer research, and cancer treatment by Dana-Farber Cancer Institute doctors and researchers.

    News Coverage

    See the latest news about Dana-Farber Cancer Institute.

    For Journalists

    Dana-Farber welcomes the opportunity to partner with journalists. Find contacts, resources, and more.

    News Videos

    Watch brief videos focusing on science, research, and advances in cancer, featuring Dana-Farber Cancer Institute doctors and researchers.

    Publications

    Read the latest issues of Dana-Farber publications, including Paths of Progress and Turning Point.

    Insight Blog

    Insight features the latest in cancer care and research news from Dana-Farber.

    Dana-Farber Spotlight

    Sign up to receive Dana-Farber Spotlight, our email newsletter.
    View sample issue
    Subscribe now
    Unsubscribe from mailings

    Unraveled: A Science Podcast

    Unraveled is a podcast produced by Dana-Farber that explores the mysteries of the science of cancer and the cutting-edge science that is transforming cancer research
  • View Our Events Calendar

    View Dana-Farber's calendar of events, including nutrition seminars, health and wellness classes, patient education, community outreach and fundraising events, and support groups.

    caregiver support group


    Participants in a caregiver support group